Myopia Outcome Study of Atropine in Children: Two-year result of daily 0.01% atropine in a European population

Authors

James Loughman, Technological University Dublin, IrelandFollow
Emmanuel Kobia-Acquah, Technological University Dublin, IrelandFollow
Gareth Lingham, Technological University DublinFollow
John Butler, Technological University DublinFollow
Ekaterina Loskutova, Technological University Dublin, IrelandFollow
David A. Mackey, University of Western Australia, Australia
Samantha S.Y. Lee, University of Western Australia, Australia
Daniel I. Flintcroft, Technological University Dublin, IrelandFollow

Document Type

Article

Disciplines

Ophthalmology

Publication Details

https://onlinelibrary.wiley.com/doi/full/10.1111/aos.15761

https://doi.org/10.1111/aos.15761

Abstract

The Myopia Outcome Study of Atropine in Children (MOSAIC) is an investigator-led, double-masked, randomized controlled trial investigating the efficacy and safety of 0.01% atropine eye drops for managing myopia progression in a predominantly White, European population.

DOI

https://doi.org/10.1111/aos.15761

Recommended Citation

Loughman, James; Kobia-Acquah, Emmanuel; Lingham, Gareth; Butler, John; Loskutova, Ekaterina; Mackey, David A.; Lee, Samantha S.Y.; and Flintcroft, Daniel I., "Myopia Outcome Study of Atropine in Children: Two-year result of daily 0.01% atropine in a European population" (2023). Articles. 94.
https://arrow.tudublin.ie/otpomart/94

Funder

Fighting Blindness Ireland, Grant/Award Number: MRCG 2016-13; Health Research Board Ireland

Creative Commons License

This work is licensed under a Creative Commons Attribution-Share Alike 4.0 International License.